Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Motiva Flora® Tissue Expander as a Support for the Creation of an Autologous Adipose Matrix for Hybrid Breast Reconstruction: a Pivotal Study

NCT06146231 is registered in ClinicalTrials.gov with Establishment Labs as lead sponsor.

NCT NCT06146231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06146231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Motiva Flora® Tissue Expander as a Support for the Creation of an Autologous Adipose Matrix for Hybrid Breast Reconstruction: a Pivotal Study
Lead sponsor
Establishment Labs
Phase
Not applicable
Overall status
Recruiting
Start date
August 18, 2023
Completion date
April 30, 2027
Enrollment
66 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, mammaplasty, poland syndrome